A group of Harvard and MIT scientists are snorting an untested COVID-19 vaccine

 A group of Harvard and MIT scientists are snorting an untested COVID-19 vaccine

If anyone who represents themselves as a lawyer has a fool for a client, then any scientists who have themselves for a lab rat better be prepared to be a dead lab rat. That’s certainly the case here. And while scientists willing to risk their lives for a medical breakthrough are a storied tradition—in the sense than they exist mostly in stories—these guys are … well … Yeah.

As MIT Technology Review reports, the group called the Rapid Deployment Vaccine Collective formed back in March, at about the time the government was announcing the first steps in what would become “Operation Warp Speed.” 

Starting with research done on the related coronaviruses SARS and MERS, the group produced a self-published white paper in July that does pretty much let any reader know what they’re getting into. It starts off with a section on informed consent and “self experimentation,” and from there goes on through headers noting that this is not medical advice, doesn’t promise to be effective, is not a clinical trial, is not approved by the FDA, and has the risk of pretty much everything. Where everything can be allergic reaction, unforeseen long-term effects, risk of infection, and a serious risk that even if none of those things occur, it simply will not work to give any protection against COVID-19. 

Those who hang in there past this point get filled in on the background of that SARS / MERS research and the relative efficiency of vaccines vs. therapeutic treatments—all of which is absolutely straightforward and sensible. They also note that in addition to be ineffective, there are a few rare cases where attempts to make a vaccine have actually ended up making subsequent infection by the disease worse. One of these cases is Dengue fever, a disease well known for being relatively mild the first time you catch it, then increasingly awful (it’s nickname is “bone break fever”) every time it recurs. So it’s not surprising that an attempt to develop a Dengue vaccine might make the disease worse rather than blocking infection. What’s less encouraging is that on this list of “they tried to fix it and ended up doubling down on infection” is SARS—COVID-19’s not at all distant cousin.

The paper then describes how they went out of their way to avoid one of the least-liked things about any vaccine, and a big obstacle to having a vaccine that can be “self administered”: the needle. To obtain a wholly snort-able vaccine while still being effective, they’ve laid this out as an initial huff followed by several booster sucks. They even cite evidence that one potential SARS vaccine elicited rapid antibody response in nasal membranes, providing better immediate protection than an injection. Which seems almost reasonable, until you remember that they have zero—that would be zero—evidence to measure the effectiveness of this I-suppose-we’ll-call-it vaccine. Not so much as an antibody test from a gerbil hit with a inhaler loaded with this stuff. If there’s a really good thing to be found in this paper, it’s that the next step is not “We based this off of live vaccine …” Instead, the paper makes a lengthy defense of the idea that the polysaccharide Chitosan (found in shrimp shells and so-called nutrition shops) and a series of peptides found in the SARS-CoV-2 virus are sufficient to generate the necessary immune response. Much of this is drawn from the previous SARS research … but again, there is absolutely no evidence that the vaccine works as described, much less that it provides immunity to the SARS-CoV-2 virus.

The availability of the peptides is the biggest obstacle to anyone wanting to whip up a batch of home brew, but RADVAC has been offering the vaccine to an expanding circle. At least 70 people have the materials. An unknown number have taken it. The original group theorizes that because they’re only handing out the white paper, complete with all those caveats, and a few simple supplies, the FDA isn’t going to come after them. It’s quite likely that they’re in for a surprise.

Does it work? They don’t know. Members of the core group doesn’t seem to have been infected, but then, that only puts them with 90% of the American population that’s in the same boat. The fact that they can’t even be sure about who has taken it means that it’s impossible to tell how effective it might be, if it’s effective at all.

But if you’re really in the mood to shoot some shrimp up your nose … ask around the nearly deserted campus at MIT. And you might also consider applying to the League.

Source link


0 Reviews

Write a Review

Related post

3a074b3ca5c6b15df8c72658184d962b27de579e Free Web Submission